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Abstract: A new diterpene, identified as (+)-6-(4-hydroxy-4-methyl-2-pentenoyl)-4,6-
dimethyl-5-(3-methyl-2-butenyl)-1,3-cyclohexadienecarbaldehyde (1, cubelin), was isolated 
from a methanol extract of Litsea cubeba fruits by normal phase column chromatography 
and purified by preparative HPLC. The structure elucidation was conducted by spectroscopic 
methods (UV, IR, ESI-TOF-MS, 1-D and 2-D NMR). Cubelin exhibited activity against 
HeLa cell viability and proliferation. The cells also exhibited changes in nuclear 
morphology which are hallmarks of apoptotic cell death. The presence of cleaved caspase-
3/-7, caspase-8 and caspase-9 in the cubelin treated population indicated the potential of 
the compound to induce apoptosis in HeLa cells via both intrinsic and extrinsic pathways. 
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1. Introduction 
Litsea cubeba (Lour.) Pers is an evergreen tree or shrub, belonging to the Lauraceae family.   
L. cubeba fruit is rich in essential oil (May Chang oil), which is produced by steam distillation.   
In China, approximately 1,500–2,000 tons of May Chang oil are produced yearly. The maximum 
essential oil content of L. cubeba fruit is approximately 5.0% of the fresh weight [1,2]. The oil is an 
economical source of citral for cosmetic and food industries. It is also an aromatherapy component as 
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an anti-depressant agent [1]. May Chang oil has been widely studied for its chemical components, 
which are mainly monoterpenes and sesquiterpenes. The major chemical constituent of this oil is citral, 
which comprises geranial (E-citral) and neral (Z-citral) [3–6]. The oil has been found to have   
bio-activities such as anti-inflammatory, antioxidant, pesticidal, antimicrobial, anticancer and 
neuropharmacological properties [7–12]. However, past research on biological active substances in  
L. cubeba fruits have mainly focused on the essential oil, while the possible existence of beneficial 
non-essential oil compounds has not been explored. Therefore, the objective of our research is to 
discover some new biological active compounds in L. cubeba fruits. In this study we focused on 
anticancer compounds by evaluating apoptosis-inducing efficiency. 
The search for new anticancer agents is an important element for the improvement of cancer 
treatment strategies. The increased understanding about the relationship between cancer and the cell 
cycle disruption has led to more attention in research on the cell cycle targeting therapeutic methods. 
Plant-derived bioactive compounds have been an important material for chemotherapy. Most of the 
chemotherapeutic drugs are active against cancer cells by restoring the function of cell cycle arrest and 
apoptosis [13]. However, there are many negative side effects from chemotherapy such as nausea, 
vomiting, diarrhea, renal toxicity, genotoxic effect and decreased blood cells [14]. Furthermore, cancer 
cells could develop resistance against chemotherapy agents by several mechanisms [15]. Therefore, 
continuous research attempts to find more new natural compounds with anticancer activity are still 
important for the future of cancer treatment. 
In the present study, a diterpene compound, identified as (+)-6-(4-hydroxy-4-methyl-2-pentenoyl)-
4,6-dimethyl-5-(3-methyl-2-butenyl)-1,3-cyclohexadienecarbaldehyde (1, cubelin, C20H28O3), was 
newly isolated from the methanol extract of L. cubeba fruits. This compound induced apoptosis in a 
human cervical cancer cell line (HeLa) by activation of the apoptotic caspase cascade. The chemical 
structure is quite unique and it has not been reported, based on a similarity search in the SciFinder and 
the ChemSpider databases. 
2. Results and Discussion 
2.1. Structure Elucidation 
Compound  1, (+)-6-(4-hydroxy-4-methyl-2-pentenoyl)-4,6-dimethyl-5-(3-methyl-2-butenyl)-1,3-
cyclohexadienecarbaldehyde, was obtained as a pale yellowish oil with a specific optical rotation [α]
20 
D  
of +274.025 (c = 0.02, CHCl3) and maximum UV absorptions at 216 and 324 nm. The molecular 
weight minus a hydroxyl group was determined by HRESIMS as C20H28O2 (obsd. at m/z 299.2017 
[M−OH+H]
+, cald. m/z 299.2011) and another peak was observed as C20H27O3Na
+ (obsd. at m/z 
339.1911 [M+Na]
+, cald. m/z 339.1936). The data suggested that the molecular formula of 1 is 
C20H28O3 (m/z 316), which indicated seven degrees of unsaturation. The IR spectrum showed hydroxyl 
group (3516–3393 cm
−1, broad), unsaturated carbons (3034 cm
−1), saturated carbons (2978 cm
−1) and 
overlapping bands of conjugated aldehyde and ketone (1670 cm
−1) absorption bands. 
The structure elucidation was explained based on NMR spectroscopic data (Table 1). Chemical 
shifts (δ) were reported in part per million (ppm), standardized by chemical shift of TMS and residue 
of CDCl3. In total, 20 signals were observed in the 
13C-NMR spectrum. Signals interpreted by the Molecules 2014, 19  6840 
 
 
DEPT experiment suggested the presence of six aliphatic methyls at δ 16.46, 17.85, 24.04, 25.81, 
29.26 and 29.47, one aliphatic methylene at δ 25.57, one aliphatic methine at δ 46.27, one aliphatic 
quaternary carbon at δ 52.99, one tertiary oxygenated carbon at δ 71.20, five olefinic methine carbons 
at δ 118.94, 121.83, 123.09, 148.45 and 153.04, three tertiary olefinic carbons at δ 132.60, 136.37 and 
156.38, one aldehyde carbon at δ 193.06 and one ketone carbon at δ 200.28. These data supported the 
molecular formula as C20H28O3. The 
1H-NMR spectrum revealed one aldehyde proton at δ 9.46 (1H, s) 
and six methyl groups at δ  1.28, 1.30, 1.39, 1.52, 1.62 and 1.95 (3H, s). According to the correlation 
based on the 
1H-
1H COSY spectrum, a methylene group at δ 2.08 (2H, dd, J = 6.50, 7.56 Hz) has spin 
coupling with two adjacent protons which are an aliphatic methine proton at δ 2.73 (1H, t,   
J = 6.50 Hz) and a vinyl methine proton at δ  5.04 (1H, t, J = 1.38, 7.56 Hz). This datum indicated the 
existence of a [C=C(13)H-C(4)H2-C(8)H-] fragment. In addition, two vinyl methine protons at δ 6.54 and 
δ 6.88 (1H, d, J = 15.12 Hz), and two methine protons at δ 5.87 and δ 6.83 (1H, d, J = 5.52 Hz) were 
also correlated to be a [-C(12)H=C(17)H-] fragment, and a [C=C(11)H-C(16)H=C] fragment, respectively. 
Table 1. 
1H and 
13C-NMR correlation based on HETCOR spectrum for cubelin in CDCl3  
(δ in ppm, J in Hz). 
Position  δ 
13C  δ 
1H   No.  δ 
13C  δ
 1H 
1  16.4  1.39 (3H, s)  11  118.9  5.87 (1H, d, J = 5.52) 
2  17.8  1.52 (3H, s)  12  121.8  6.54 (1H, d, J = 15.12) 
3  24.0  1.95 (3H, s)  13  123.0  5.04 (1H, t, J = 1.38, 7.56) 
4 25.5 
2.08 (2H, dd, J = 6.50, 
7.56) 
14 132.6   
5  25.8  1.62 (3H, s)  15  136.3   
6  29.2  1.28 (3H, s)  16  148.4  6.83 (1H, d, J = 5.52) 
7  29.4  1.30 (3H, s)  17  153.0  6.88 (1H, d, J = 15.12) 
8  46.2  2.73 (1H, t, J = 6.50)  18  156.3   
9  52.9    19  193.0  9.46 (1H, s) 
10 71.2    20  200.2   
The chemical structure of cubelin (Figure 1) was constructed based on the long ranged proton-
carbon correlations as displayed in the HMBC spectrum (Figure 2A). As for the fragment containing 
[C=C(13)H-C(4)H2-C(8)H-] unit assigned by J coupling with H-13, H-4 and H-8, the correlations 
between H-13 and C-5, H-5 and C-2, C-14, and H-2 and C-13, C-14 were clearly observed and 
suggested connections between C-14 and two terminal methyl groups. This data set established the 
partial structure A (Figure 1). From the [-C(12)H=C(17)H-] fragment, correlation between H-12 and  
C-10, C-20, and then between H-17 and C-10, C-20, between H-6 and C-7, C-10, C-17 and between 
H-7 and C-10, C-17, suggested a connection between C-12 and C-20. C-17 is attached to C-10, which 
is also connected to two terminal methyl groups. The chemical shift of C-10 (δ 71.20) suggested the 
presence of a hydroxyl group. These data clearly supported the partial structure B (Figure 1). For the 
fragment containing the [C=C(11)H-C(16)H=C] unit, cross-peaks between H-16 and C-9, C-18, C-19, 
and between H-19 and C-9, C-15, as well as between H-11 and C-15 suggested a connection between 
C-19 and C-15. Therefore, C-15 should be connected to C-16 and C-9. At the other edge of the 
fragment, cross-peaks between H-3 and C-11, C-18 suggested that C-11 is connected to C-18 with a Molecules 2014, 19  6841 
 
 
methyl group (H-3). This data set established the partial structure C (Figure 1). Finally, the correlation 
between H-8 and C-9, C-11, C-13, C-15, C-18, C-20 and between H-1 and C-8, C-9, C-15, C-20 
enabled construction of the entire chemical structure of cubelin (Figure 1) by connecting all three 
partial structures, because the connection of C-8 to both C-9 and C-18 suggested the presence of a 
monocyclic structure. Obvious NOE signals were observed between H-12 and H-6/7, H-17 and   
H-6/7, H-19 and H-16, H-11 and H-3, H-13 and H-5 (Figure 2B). The present result still does not 
clarify the configuration at C-8 and C-9, but since two monoterpene units composed by head to tail 
connection of isoprene units were conjugated at C-8 and C-9; C-15 and C-16, we suppose that both 
major side chains at C-8 and C-9 might have trans-configurations because of the steric hindrance. 
Figure 1. Chemical structure of cubelin (1) and its partial structures A, B and C. The 
numeration was assigned based on the 
13C-NMR spectroscopic data. 
 
Figure 2. HMBC and 
1H-
1H COSY correlations (A) and NOESY correlations (B) of cubelin. 
 
We have not found any reported chemicals in L. cubeba or even in the Litsea genus that have a 
chemical skeleton similar to cubelin. However, partial structure C (Figure 1) is related to that of 
geranial and neral, which are the major components of L. cubeba fruit essential oil. Therefore, we 
presume that cubelin might be biosynthesized from conjugation of these compounds. A proposed 
biosynthesis of cubelin is shown in Figure 3. Molecules 2014, 19  6842 
 
 
Figure 3. Proposed biosynthesis pathway of cubelin. The numeration in cubelin structure 
was assigned based on the rule of IUPAC nomenclature. 
 
2.2. The Anticancer Potential of Cubelin 
Cancer generally occurs as a consequence of mutation in genes that modulate tissue homeostasis. 
More than half of all human cancers are caused by loss of the tumor suppressor p53 function, which 
regulates cell cycle arrest and the apoptotic caspase cascades. Mutation of the p53 gene leads to 
declined apoptotic cell death and unlimited cell proliferation [16,17]. Apoptosis is a biological process 
that eliminates defected cells without causing inflammatory responses [18]. The major enzymes 
involved in this process are proteolytic enzymes in caspase family. The effector, caspase-3/-7 regulates 
apoptosis by cleaving cytoskeleton proteins, nuclear proteins and cell survival relating proteins. 
Zymogens of the effector caspases must be cleaved by the initiator caspases to convert into their active 
form. Initiators, caspase-8 and -9 are activated through different pathways, which are the death receptors 
(extrinsic) and the mitochondrial released cytochrome c (intrinsic) pathways, respectively [19]. 
In this study, we determined the potential of cubelin to induce apoptosis in the human cervical 
cancer cell (HeLa). The positive control used in this study was etoposide (VP-16), which is an 
anticancer drug that promotes apoptosis by inhibition of topoisomerase II [20,21]. Firstly, we investigated 
effect of cubelin on viability (WST-8 formazan measurement), proliferation (BrdU incorporation) and Molecules 2014, 19  6843 
 
 
release of LDH (INT formazan measurement) in the HeLa cell populations that were exposed to 
various concentrations of cubelin and etopside (1–100 µM) for 24 and 48 h. 
According to the results in Table 2, cubelin was effective against HeLa cell viability with an 
average IC50 of 34.43 mM at 24 h and 21.92 at 48 h. The amount of replicating DNA in the cubelin- 
treated population was also decreased (IC50: 30.49 µM at 24 h and 24.08 µM at 48 h). This data 
suggested that cubelin suppressed HeLa cell proliferation. Leakage of LDH from cytoplasm is an 
indicator for cell membrane rupture, which occurs as a result of secondary necrosis in the late 
apoptosis stage in vitro [22,23]. It was found that cubelin exhibited mild activity on LDH leakage 
(IC50: 179.21 µM at 24 h and 144.55 µM at 48 h). However, etoposide also exhibited a similar effect 
with even weaker activity. This result indicated that LDH leakage in the cubelin- and etoposide-treated 
populations did not occur immediately after the test compounds were administered. Therefore, it could 
be assumed that cubelin might induce cell death by apoptosis rather than necrosis, which is a type of 
cell death that rapidly occurs as a result of external stress and causes inflammatory responses that 
damage the surrounding cells [24]. 
Table 2. Activity of cubelin and etoposide on HeLa cells viability, proliferation and LDH leakage. 
Time/Sample 
IC50 (µM) 
a 
Cell viability  LDH leakage  Cell proliferation 
24 h 
Cubelin  34.43 ± 4.87  179.21 ± 6.23  30.49 ± 4.29 
Etoposide  62.90 ± 5.48  No activity  34.24 ± 5.59 
48 h 
Cubelin  21.92 ± 3.58  144.55 ± 2.43  24.07 ± 1.55 
Etoposide  4.52 ± 1.02  201.17  3.17 ± 1.96 
a IC50 values were calculated from dose-response curves after 24 h and 48 h of exposure. 
The cells undergoing apoptosis have specific morphological changes which are: (1) cell membrane 
blebbing; (2) condensation and margination of DNA and (3) fragmentation of nuclei. Apoptotic bodies 
are formed after these changes and then they are eliminated by phagocytosis [19,21]. Figure 4 shows a 
fluorescent microscopic view of HeLa cells that were exposed to 50 µM of cubelin for 24 h, compared 
with that of the untreated population. Nuclear content were revealed by Hoechst 33342 staining.   
The cubelin treated cells exhibited morphological characteristics of apoptotic cell. Nuclei breakdown 
was observed as well as chromatin condensation (Figure 4A), while the untreated cells did not exhibit 
these characteristics (Figure 4D). Identification of dead cells was done by propidium iodide (PI) 
staining, which is a nucleotide binding dye that lacks of cell membrane permeability. More PI   
positive cells were observed in the cubelin treated population (Figure 4B) when compare to the 
untreated cells (Figure 4E). Figure 4C,F display the cells stained with fluorescent caspase-3/-7 
inhibitor (FAM-DEVD-FMK) in the cubelin treated population and the untreated population, 
respectively. Significant intensity of the dye was observed only in the cubelin treated population. This 
result is the important evidence that suggest about apoptosis induction potential of cubelin. 
  Molecules 2014, 19  6844 
 
 
Figure 4. Chromatin condensation pattern in the HeLa cells treated with 50 µM cubelin 
(A) and in the untreated population (D) was revealed by using Hoechst 33342. Dead cells 
in the cubelin treated (B) and the untreated population (E) were revealed by PI. The 
presence of caspase-3/-7 was clearly evident in the cubelin treated cells (C), while that in 
the untreated population (F) was not obvious. 
 
The cleaved effector and initiator caspases in the cubelin treated HeLa cell population was 
measured quantitatively at 6–30 h after administration of cubelin (50 µM) and etoposide (50 µM).  
The result is presented as folds of the spontaneously cleaved caspases in the untreated population 
(Figure 5). The amount of cleaved caspase-8 in cubelin treated population gradually increased from 
1.7, 2.0, 2.8, 3.5, and 4.5 folds, respectively (Figure 4A). The amount of cleaved caspase-9 did not 
significantly increase at 6–18 h, but increased sharply to 1.9 folds at 18 h, to 4.2 folds at 24h and then 
reached 5.0 folds at 30 h (Figure 4B). This result suggested that administration of cubelin had an effect 
on activation of initiator caspase-8 and -9, which lead to activation of the effector caspase-3/-7 which 
is the major manipulator of apoptosis. The amount of caspase-3/-7 in the cubelin treated population 
gradually increased from 1.1, 1.8, 2.7, 2.9 and 3.3 folds of that in the untreated population at 6, 12, 18, 
24 and 30 h of exposure, respectively (Figure 4C). These data clearly suggested the potential of 
cubelin on the caspase cascade in HeLa cells. This compound was found to be effective in promotion 
of apoptosis via both the death receptor pathway (caspase-8 activation) and the mitochondrial released 
cytochrome c (caspase-9 activation). 
In this study, we found that this new diterpene compound from L. cubeba fruit has potential as an 
anticancer agent. In comparision to etoposide, which is a clinical cancer drug, cubelin exhibited 
slightly lower activity in promoting caspase cascades (Figure 5). The apoptosis-inducing effect of  
cubelin is very interesting for further study to investigate the exact anticancer mechanism, such as 
inhibition of topoisomerase, the effect on function of oncogenes and tumor suppressor genes, and the 
structure-activity relationship. 
  Molecules 2014, 19  6845 
 
 
Figure 5. Effect of cubelin and etoposide (50 µM) on induction of HeLa cell apoptosis. 
Activity of caspase-8 (A), caspase-9 (B) and caspase-3/-7 (C) were measured and 
compared with that of the untreated population.  
 
Another noteworthy point is that cubelin has a new chemical skeleton. This compound might be 
useful as a lead compound for further development of more effective anticancer agents. 
3. Experimental Section 
3.1. General Experimental Procedures 
Optical rotation was recorded on a P-1030 polarimeter (JASCO International, Tokyo, Japan). 1-D 
NMR spectra (
1H, 
13C and DEPT) and 2-D NMR spectra (
1H-
1H COSY, HETCOR, HMBC and 
NOESY) at 600 MHz was recorded in CDCl3 with 0.05% TMS as the internal standard, using a JEOL 
ECA-600 spectrometer (JEOL, Tokyo, Japan). The chemical shifts (δ) are reported in parts per million 
(ppm) referenced by signals of TMS and residue of CDCl3. The HRESIMS spectrum was recorded on 
a Waters Xevo QTOF-MS spectrometer (Waters Corporation, Milford, MA, USA). The UV-VIS 
spectrum was recorded on a Shimadzu SPD-M20 Diode Array Detector (Shimadzu Corporation, 
Kyoto, Japan). The IR spectrum was recorded on a Jasco FT-IR-400 spectrometer. 
3.2. Plant Material 
Fruits of Litsea cubeba were harvested in September 2010, from a mountainous area in Mae-Rim 
district, Chiang Mai, Thailand. The fresh fruits were washed and air dried before shipping to Japan by 
airmail. The voucher specimen (LC14001TAFS6-1) has been deposited at The Research Institute of 
Food Safety and Nutraceutical Science, Kagawa University, Japan. Molecules 2014, 19  6846 
 
 
3.3. Extraction, Isolation and Identification of (+)-6-(4-Hydroxy-4-methyl-2-pentenoyl)-4,6-dimethyl-
5-(3-methyl-2-butenyl)-1,3-cyclohexadienecarbaldehyde (Cubelin, 1) 
Air dried L. cubeba fruits (2 kg) were ground into a coarse powder and then extracted with hexane 
(3× 4L). The remaining fruit residue was extracted again with methanol (3× 4L). After the methanol 
extract was filtered and the solvent was removed under vacuum, the extract (300 g) was dissolved in 
diethyl ether (2 L). The diethyl ether soluble filtrate (50 g) was then subjected to silica gel column 
chromatography (Wakogel C-300, 200 × 50 mm, 45–75 μm particle size) after the solvent was removed. 
Elution was done with mixtures of hexane and diethyl ether (1:0, 3:1, 1:1, 1:3 and 0:1, 1L each) to give 
20 fractions (250 mL/fraction). Fraction 11 and 12, which were eluted by 1:1 mobile phase, were 
subjected to preparative RP-HPLC (Mightysil RP-18GP, 250 × 10 mm, isocratic: 54% Acetonitrile, 
0.1% TFA in H2O, flow rate: 0.6 mL/min, UV-VIS detector: 230 nm) to afford cubelin (retention time: 
120–125 min). The amount of cubelin obtained from 2 kg of fresh fruit was 64 mg. Pale yellowish oil; 
[α]
20 
D  +274.025 (c = 0.02, CHCl3); UV λmax (logε): 216 (2.99), 324 (2.69) nm; IR (KBr): υmax 3597, 
3516–3393 (broad), 3034, 3010, 2978, 1670, 1629, 1561 cm
−1; HRESIMS: m/z 299.2017 [M−OH+H]
+ 
(calcd. 299.2011 for C20H28O2), m/z 339.1911 [M+Na]
+ (cald. m/z 339.1936 for C20H28O3Na
+). 
1H and 
13C-NMR data are shown in Table 1. 
3.4. General Procedure on Cell Culture and Cell Based Assays 
The Human Cervical Cancer cell line (HeLa) was purchased from the RIKEN Bioresource Center, 
(Ibaraki, Japan). The stock culture was grown in EMEM, supplemented with 4.2 mM HEPES, 10% 
FBS, 0.1 mg/mL penicillin and streptomycin. Incubating condition was set to 37 °C, humidified 
atmosphere with 5% CO2. Exponentially growing cells were harvested and incubated in assay vessels 
for 24 h prior to sample administration. All test samples were dissolved in DMSO, which final 
concentration did not exceed 0.1%. Untreated population was exposed to 0.1% DMSO. Treated 
populations in cell viability, cell proliferation and LDH determination assays were exposed to 1–100 µM 
of cubelin and etoposide (positive control). Absorbance in colorimetric assays was recorded on a 
Multiskan™ FC Microplate Photometer. The IC50 values were calculated with GraphPad Prism 5.0. 
3.5. Cell Viability Assay 
Cell viability was determined by using a Cell Counting Kit-8 (Dojindo Molecular Technologies, 
Kumamoto, Japan). In a 96-well transparent cell culture plate, HeLa cells (3 × 10
3 cells/well) were 
exposed to the test samples for 24 and 48 h. Ten microliter of CCK-8 reagent was added to each well 
then the cells were further incubated for 240 min. The absorbance was recorded at 450 nm.   
Cell viability in each treated population was expressed as viability percentage compared to the 
untreated population. 
3.6. Cell Proliferation Assay (BrdU Incorporation) 
The cell proliferation assay was carried out by using the cell proliferation ELISA BrdU 
(colorimetric) kit (Roche Applied Science, Penzberg, Germany). HeLa cells (1 × 10
4 cells/well) were 
exposed to the test samples for 24 and 48 h and then labeled with BrdU solution (100 µM) for 120 min Molecules 2014, 19  6847 
 
 
under the cell incubating condition. The cells were fixed with a FixDenat solution and then exposed to 
the Anti-BrdU peroxidase solution for 90 min at room temperature. After washing, tetramethylbenzidine 
(TMB) was added to reveal the immune complex. H2SO4 (0.2 M) was used as a stop solution. 
Absorbance value was recorded at 450 nm and the cell proliferation percentage of each treated 
population was calculated by comparing to the untreated population. 
3.7. Determination of LDH Leakage 
Determination of LDH was performed with a Cytotoxicity Detection Kit 
plus (Roche Applied 
Science, Penzberg, Germany). EMEM supplemented with 1% FBS was used as an assay medium and 
two sets of untreated population were assigned. HeLa cell at 5 × 10
3 cells/well density was exposed to 
the test samples for 24 and 48 h. One set of untreated population was treated with 5% Triton-X-100 for 
15 min, representing maximum LDH leakage in the certain cell population size (high control). The 
amount of LDH was determined by adding a mixture of tetrazolium salt INT, sodium lactate, NAD
+ 
and diaphorase, and incubating for 4 min at room temperature. HCl (1 N) was used as a stop solution. 
The absorbance was measured at 492 nm. The percentage of leaked LDH was calculated in comparison 
to the absorbance of high control after subtraction of the absorbance of untreated population. 
3.8. Determination of Activated Caspase-8, Caspase-9 and Caspase-3/-7 
Determination of caspases was carried out using a Caspases Determination Kit―FAM-FLICA 
(Immunochemistry Technologies, LLC, Bloomington, MN, USA). Caspase substrate FAM-LETD-
FMK, FAM-LEHD-FMK and FAM-DEVD-FMK were used for labeling caspase-8, caspase-9 and 
caspase-3/-7, respectively. HeLa cell suspension (8 × 10
4 cells/mL) were seeded into 100 mm 
petridishes and incubated for 24 h. The cells were exposed to cubelin (50 µM), etoposide (50 µM) and 
DMSO (0.1%) for 6–36 h. Treated cells were harvested by using a trypsin solution (0.25% w/v).  
The cell suspension was spun (400 ×g) and re-suspended in the culture medium and the cell density 
was adjusted to 4 × 10
6 cells/mL. The cell suspensions were separately exposed to each caspase 
substrates (1:150) for 90 min at 37°C. Excessive substrate was neutralized by washing solution 
containing mammalian proteins and 0.01% sodium azide. After washing, the cells were re-suspended 
in PBS and the cell concentration was adjusted to 2.5 × 10
6 cells/mL. The cell suspension was 
transferred into black solid 96-well plates (100 µL/well). Relative fluorescent unit (RFU) was 
measured at 485 nm excitation and 530 nm emission wavelengths on a CYTOFLUOR series 4000 
fluorescent plate reader. 
3.9. Fluorescent Microscope Analysis 
FAM-DEVD-FMK and PI dual staining was conducted following the method of caspases 
determination assay. The cells stained with FAM-DEVD-FMK was exposed to PI (1.25 µg/mL) for  
10 min at 37 °C. Hoechst 33342 staining was conducted individually. After re-suspension with culture 
medium, the cells were exposed to Hoechst 33342 (1 µg/mL) for 10 min at 37 °C. After washing, the 
cells were re-suspended in PBS and the density was adjusted to 2.5 × 10
6 cells/mL. The cell 
suspension (10 µL) was smeared on a glass slide and mounted with the ProLong
® Gold antifade Molecules 2014, 19  6848 
 
 
reagent (Invitrogen) before being observed under fluorescent microscope (Olympus BX51, Olympus 
Optical, Tokyo, Japan) at 200× magnification. 
4. Conclusions 
A new cytotoxic diterpenoid compound, cubelin, was isolated from a methanol extract of L. cubeba 
fruits. This compound induced apoptosis in HeLa cells by promoting activation of initiator caspase-8 
and -9, resulting in an increased level of the cleaved effector caspase-3/-7. This compound has not 
been reported as one of the components in L. cubeba fruit essential oil. We proposed a hypothesis that 
cubelin might be biosynthesized from neral and geranial, which are major components of the oil. 
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study was supervised by Tamura Hirotoshi. 
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